Obstructive sleep apnea was common in never-smokers with lung cancer. Read more about the prospective findings.
MedPage Today on MSN
Next-Gen Nerve Stimulator Approved for Obstructive Sleep Apnea
Device will not carry concentric collapse contraindication or warning language ...
There are options for sleep apnea & TMJ relief (sponsored) ...
Individuals with chronic obstructive pulmonary disease (COPD) with coexisting obstructive sleep apnea (OSAS) have greater ...
Mild, intermittent oxygen deprivation in preterm infants disrupts brain connectivity, alters neuron development, and may ...
The Apple Watch Ultra 2 is a 49mm smartwatch designed to help you track your progress during athletic events and other ...
The FDA has approved the proximal hypoglossal nerve stimulation device (aura6000 system) developed by LivaNova for adults ...
An April 10, 2026 PDUFA positions orforglipron to compete with oral semaglutide across diabetes and obesity markets ...
Eli Lilly (LLY) stock trades flat as J.P. Morgan says that adverse events offset a late-stage trial win for company's ...
Overseas conflict and your retirement portfolio (sponsored) ...
First and only hypoglossal nerve stimulation therapy approved in the U.S. without complete concentric collapse contraindication or warning language – Next-generation, MRI-compatible device expected to ...
CHEST and its Women in Chest Medicine interest group helped Ghada Bourjeily, MD, transform the management of sleep issues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results